Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.5M Buy
211,511
+8,466
+4% +$2.11M 1.69% 25
2025
Q4
$48.9M Buy
203,045
+1,663
+0.8% +$425K 1.86% 23
2025
Q3
$55.1M Buy
201,382
+3,017
+2% +$824K 2.24% 17
2025
Q2
$51.2M Buy
198,365
+9,147
+5% +$2.18M 2.31% 15
2025
Q1
$42.4M Buy
189,218
+4,630
+3% +$1.08M 2.09% 17
2024
Q4
$42.2M Buy
184,588
+5,310
+3% +$1.28M 2.13% 17
2024
Q3
$43.8M Buy
179,278
+3,781
+2% +$845K 2.17% 17
2024
Q2
$33.7M Buy
+175,497
New +$35.6M 1.88% 19

Other funds holding RMD

Aviso Financial's RMD Position: Q1 2026 in Review

Aviso Financial increased its ResMed (RMD) stake by 4.2% in Q1 2026, buying an estimated $2.11M and bringing the position to 211,511 shares worth $47.5M. The position accounts for 1.69% of the portfolio, ranked #25.

Aviso Financial first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $55.1M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Aviso Financial held 211,511 shares of ResMed worth $47.5M as of Q1 2026.
  • Aviso Financial bought 8,466 ResMed shares in Q1 2026, an estimated $2.11M.
  • ResMed made up 1.69% of Aviso Financial's portfolio in Q1 2026, its #25 holding.
  • Aviso Financial first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
  • Aviso Financial's ResMed position peaked at $55.1M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.